- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2662-8651
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Untangling the KRAS mutated lung cancer subsets and its therapeutic implications ; volume:2 ; number:1 ; day:17 ; month:12 ; year:2021 ; pages:1-13 ; date:12.2021
Molecular biomedicine ; 2, Heft 1 (17.12.2021), 1-13, 12.2021
- Creator
-
Ritu, Kulshrestha
Kumar, Pawan
Singh, Amit
Nupur, K.
Spalgias, Sonam
Mrigpuri, Parul
Rajkumar
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-021-00061-0
- URN
-
urn:nbn:de:101:1-2022041219013944512813
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ritu, Kulshrestha
- Kumar, Pawan
- Singh, Amit
- Nupur, K.
- Spalgias, Sonam
- Mrigpuri, Parul
- Rajkumar
- SpringerLink (Online service)
Other Objects (12)
Sotorasib in KRAS p.G12C-Mutated Pulmonary Sarcomatoid Carcinoma: Therapeutic Efficacy of a KRAS Inhibitor in Symptomatic Brain Metastases
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib
Long-Term Survival with Regorafenib in KRAS-Mutated Metastatic Rectal Cancer
Untangling feminist theory
Untangling Real Gravity
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines
CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma
Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk
Untangling performance from success
Sotorasib in KRAS p.G12C-Mutated Pulmonary Sarcomatoid Carcinoma: Therapeutic Efficacy of a KRAS Inhibitor in Symptomatic Brain Metastases
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib
Long-Term Survival with Regorafenib in KRAS-Mutated Metastatic Rectal Cancer
Untangling feminist theory
Untangling Real Gravity
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines
CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma
Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk
Untangling performance from success
Sotorasib in KRAS p.G12C-Mutated Pulmonary Sarcomatoid Carcinoma: Therapeutic Efficacy of a KRAS Inhibitor in Symptomatic Brain Metastases
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib
Long-Term Survival with Regorafenib in KRAS-Mutated Metastatic Rectal Cancer
Untangling feminist theory
Untangling Real Gravity
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines
CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma
Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk